Skip to main content
Top
Published in: Journal of Ophthalmic Inflammation and Infection 1/2013

Open Access 01-12-2013 | Original research

Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections

Authors: Jayanth Sridhar, Harry W Flynn Jr, Ajay E Kuriyan, Darlene Miller, Thomas Albini

Published in: Journal of Ophthalmic Inflammation and Infection | Issue 1/2013

Login to get access

Abstract

Background

The purpose of the current study was to analyze risk factors, clinical features, and treatment outcomes in patients with endogenous fungal endophthalmitis with yeast and mold infections. For this retrospective consecutive case series, microbiologic and clinical records were reviewed to identify all patients with intraocular culture-proven endogenous fungal endophthalmitis treated at a single institution between January 1, 1990 and December 31, 2011.

Results

Sixty-seven eyes of 53 patients were identified; 51 eyes of 39 patients had positive cultures for yeast and 16 eyes of 14 patients had positive cultures for molds. Patients with molds as a causative organism had significantly shorter duration of symptoms prior to diagnosis (molds 3.8 days, yeast 21.0 days, p = 0.002), were more likely to be receiving iatrogenic immunosuppression (molds 57.1%, yeast 7.7%, p = 0.001), have a history of whole-organ transplantation (molds 35.7%, yeast 2.6%, p = 0.001), and were more likely to have hypopyon at the time of diagnosis (molds 37.5%, yeast 6.0%, p = 0.001). Patients with endogenous endophthalmitis caused by molds had significantly worse visual acuity at the time of diagnosis (logMAR visual acuity molds 1.80, yeast 1.15, p = 0.008) and at final visit (logMAR visual acuity molds 1.97, yeast 1.05, p = 0.005) compared to those patients with yeast as a causative organism. There was no significant difference in the rate of retinal detachment between the two groups (mold 12.5%, yeast 30.6%, p = 0.201). Patients with cultures positive for mold were significantly more likely to undergo enucleation (molds 25.0%, yeast 0%, p < 0.001).

Conclusions

Systemic risk factors for patients with endogenous fungal endophthalmitis caused by molds were iatrogenic immunosuppression and a history of whole-organ transplantation. Shorter duration of symptoms before diagnosis and higher rates of hypopyon occurred in mold cases. While endogenous fungal endophthalmitis is generally associated with poor visual acuity outcomes, infection with mold species was associated with worse visual acuity on presentation and on final follow-up than infection with yeast species. Enucleation rates were much higher in mold cases.
Appendix
Available only for authorised users
Literature
1.
go back to reference Schiedler V, Scott IU, Flynn HW Jr, Davis JL, Benz MS, Miller D: Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol 2004,137(4):725–731.PubMed Schiedler V, Scott IU, Flynn HW Jr, Davis JL, Benz MS, Miller D: Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol 2004,137(4):725–731.PubMed
2.
go back to reference Chhablani J: Fungal endophthalmitis. Expert Rev Anti Infect Ther 2011,9(12):1191–1201. 10.1586/eri.11.139PubMedCrossRef Chhablani J: Fungal endophthalmitis. Expert Rev Anti Infect Ther 2011,9(12):1191–1201. 10.1586/eri.11.139PubMedCrossRef
3.
go back to reference Lingappan A, Wykoff CC, Albini TA, Miller D, Pathengay A, Davis JL, Flynn HW Jr: Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol 2012,153(1):162–166.e1. 10.1016/j.ajo.2011.06.020PubMedCrossRef Lingappan A, Wykoff CC, Albini TA, Miller D, Pathengay A, Davis JL, Flynn HW Jr: Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol 2012,153(1):162–166.e1. 10.1016/j.ajo.2011.06.020PubMedCrossRef
4.
go back to reference Kostick DA, Foster RE, Lowder CY, Meyers SM, McHenry MC: Endogenous endophthalmitis caused by Candida albicans in a healthy woman. Am J Ophthalmol 1992,113(5):593–595.PubMedCrossRef Kostick DA, Foster RE, Lowder CY, Meyers SM, McHenry MC: Endogenous endophthalmitis caused by Candida albicans in a healthy woman. Am J Ophthalmol 1992,113(5):593–595.PubMedCrossRef
5.
go back to reference Mamandhar A, Bajracharya L: Endogenous aspergillus endophthalmitis in a healthy individual. Nepal J Ophthalmol 2012,4(7):179–183.PubMed Mamandhar A, Bajracharya L: Endogenous aspergillus endophthalmitis in a healthy individual. Nepal J Ophthalmol 2012,4(7):179–183.PubMed
6.
go back to reference Essman TF, Flynn HW Jr, Smiddy WE, Brod RD, Murray TG, Davis JL, Rubsamen PE: Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis. Ophthalmic Surg Lasers 1997,28(3):185–194.PubMed Essman TF, Flynn HW Jr, Smiddy WE, Brod RD, Murray TG, Davis JL, Rubsamen PE: Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis. Ophthalmic Surg Lasers 1997,28(3):185–194.PubMed
7.
go back to reference Riddell Iv J, McNeil SA, Johnson TM, Bradley SF, Kazanjian PH, Kauffman CA: Endogenous Aspergillus endophthalmitis: report of 3 cases and review of the literature. Medicine (Baltimore) 2002,81(4):311–320. 10.1097/00005792-200207000-00007CrossRef Riddell Iv J, McNeil SA, Johnson TM, Bradley SF, Kazanjian PH, Kauffman CA: Endogenous Aspergillus endophthalmitis: report of 3 cases and review of the literature. Medicine (Baltimore) 2002,81(4):311–320. 10.1097/00005792-200207000-00007CrossRef
8.
go back to reference Binder MI, Chua J, Kaiser PK, Procop GW, Isada CM: Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center. Medicine (Baltimore) 2003,82(2):97–105. 10.1097/00005792-200303000-00004CrossRef Binder MI, Chua J, Kaiser PK, Procop GW, Isada CM: Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center. Medicine (Baltimore) 2003,82(2):97–105. 10.1097/00005792-200303000-00004CrossRef
9.
go back to reference Sutton DA, Fothergill AW, Rinaldi MG: Guide to clinically significant fungi. 1st edition. Baltimore: Williams & Wilkins; 1997:471. Sutton DA, Fothergill AW, Rinaldi MG: Guide to clinically significant fungi. 1st edition. Baltimore: Williams & Wilkins; 1997:471.
10.
go back to reference Larone DH: Medically important fungi: a guide to identification. 4th edition. Washington, D.C: ASM Press; 2002:409. Larone DH: Medically important fungi: a guide to identification. 4th edition. Washington, D.C: ASM Press; 2002:409.
11.
go back to reference Rebell GC, Forster RK In: Manual of clinical microbiology. In Fungi of keratomycosis. 3rd edition. Washington, D.C: American Society for Microbiology; 1980:553–561. Rebell GC, Forster RK In: Manual of clinical microbiology. In Fungi of keratomycosis. 3rd edition. Washington, D.C: American Society for Microbiology; 1980:553–561.
12.
go back to reference Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M: Visual acuities “hand motion” and “counting fingers” can be quantified with the Freiburg visual acuity test. Invest Ophthalmol Vis Sci 2006, 47: 1236–1240. 10.1167/iovs.05-0981PubMedCrossRef Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M: Visual acuities “hand motion” and “counting fingers” can be quantified with the Freiburg visual acuity test. Invest Ophthalmol Vis Sci 2006, 47: 1236–1240. 10.1167/iovs.05-0981PubMedCrossRef
13.
go back to reference Bach M, Schulze-Bonsel K, Feltgen N, Burau H, Hansen L: Author response: numerical imputation for low vision states [electronic letter]. Invest Ophthalmol Vis Sci 2007. Bach M, Schulze-Bonsel K, Feltgen N, Burau H, Hansen L: Author response: numerical imputation for low vision states [electronic letter]. Invest Ophthalmol Vis Sci 2007.
14.
go back to reference Shrader SK, Band JD, Lauter CB, Murphy P: The clinical spectrum of endophthalmitis: incidence, predisposing factors, and features influencing outcome. J Infect Dis 1990,162(1):115–120. 10.1093/infdis/162.1.115PubMedCrossRef Shrader SK, Band JD, Lauter CB, Murphy P: The clinical spectrum of endophthalmitis: incidence, predisposing factors, and features influencing outcome. J Infect Dis 1990,162(1):115–120. 10.1093/infdis/162.1.115PubMedCrossRef
15.
go back to reference Connell PP, O’Neill EC, Amirul Islam FM, Buttery R, McCombe M, Essex RH, Roufail E, Lash S, Wolffe B, Clark B, Chiu D, Campbell W, Allen P: Endogenous endophthalmitis associated with intravenous drug abuse: seven-year experience at a tertiary referral center. Retina 2010,30(10):1721–1725. 10.1097/IAE.0b013e3181dd6db6PubMedCrossRef Connell PP, O’Neill EC, Amirul Islam FM, Buttery R, McCombe M, Essex RH, Roufail E, Lash S, Wolffe B, Clark B, Chiu D, Campbell W, Allen P: Endogenous endophthalmitis associated with intravenous drug abuse: seven-year experience at a tertiary referral center. Retina 2010,30(10):1721–1725. 10.1097/IAE.0b013e3181dd6db6PubMedCrossRef
16.
go back to reference Rao NA, Hidayat AA: Endogenous mycotic endophthalmitis: variations in clinical and histopathologic changes in candidiasis compared with aspergillosis. Am J Ophthalmol 2001,132(2):244–251. 10.1016/S0002-9394(01)00968-0PubMedCrossRef Rao NA, Hidayat AA: Endogenous mycotic endophthalmitis: variations in clinical and histopathologic changes in candidiasis compared with aspergillosis. Am J Ophthalmol 2001,132(2):244–251. 10.1016/S0002-9394(01)00968-0PubMedCrossRef
17.
go back to reference Anand AR, Therese KL, Madhavan HN: Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates. Indian J Ophthalmol 2000, 48: 123.PubMed Anand AR, Therese KL, Madhavan HN: Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates. Indian J Ophthalmol 2000, 48: 123.PubMed
18.
go back to reference Oude Lashof AM, Rothova A, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, Schlamm HT, Oborska IT, Rex JH, Kullberg BJ: Ocular manifestations of candidemia. Clin Infect Dis 2011,53(3):262–268. 10.1093/cid/cir355PubMedCrossRef Oude Lashof AM, Rothova A, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, Schlamm HT, Oborska IT, Rex JH, Kullberg BJ: Ocular manifestations of candidemia. Clin Infect Dis 2011,53(3):262–268. 10.1093/cid/cir355PubMedCrossRef
19.
go back to reference Shen X, Xu G: Vitrectomy for endogenous fungal endophthalmitis. Ocul Immunol Inflamm 2009,17(3):148–152. 10.1080/09273940802689396PubMedCrossRef Shen X, Xu G: Vitrectomy for endogenous fungal endophthalmitis. Ocul Immunol Inflamm 2009,17(3):148–152. 10.1080/09273940802689396PubMedCrossRef
20.
go back to reference Foster RE, Rubsamen PE, Joondeph BC, Flynn HW Jr, Smiddy WS: Concurrent endophthalmitis and retinal detachment. Ophthalmology 1994,101(3):490–498.PubMedCrossRef Foster RE, Rubsamen PE, Joondeph BC, Flynn HW Jr, Smiddy WS: Concurrent endophthalmitis and retinal detachment. Ophthalmology 1994,101(3):490–498.PubMedCrossRef
21.
go back to reference Doft BM, Kelsey SF, Wisniewski SR: Retinal detachment in the endophthalmitis vitrectomy study. Arch Ophthalmol 2000,118(12):1661–1665. 10.1001/archopht.118.12.1661PubMedCrossRef Doft BM, Kelsey SF, Wisniewski SR: Retinal detachment in the endophthalmitis vitrectomy study. Arch Ophthalmol 2000,118(12):1661–1665. 10.1001/archopht.118.12.1661PubMedCrossRef
22.
go back to reference Flynn HW Jr, Scott IU: Legacy of the endophthalmitis vitrectomy study. Arch Ophthalmol 2008,126(4):559–561. 10.1001/archopht.126.4.559PubMedCrossRef Flynn HW Jr, Scott IU: Legacy of the endophthalmitis vitrectomy study. Arch Ophthalmol 2008,126(4):559–561. 10.1001/archopht.126.4.559PubMedCrossRef
23.
go back to reference Sallam A, Taylor SR, Khan A, McCluskey P, Lynn WA, Manku K, Pacheco PA, Lightman S: Factors determining visual outcome in endogenous candida endophthalmitis. Retina 2012,32(6):1129–1134. 10.1097/IAE.0b013e31822d3a34PubMedCrossRef Sallam A, Taylor SR, Khan A, McCluskey P, Lynn WA, Manku K, Pacheco PA, Lightman S: Factors determining visual outcome in endogenous candida endophthalmitis. Retina 2012,32(6):1129–1134. 10.1097/IAE.0b013e31822d3a34PubMedCrossRef
24.
go back to reference Zhang YQ, Wang WJ: Treatment outcomes after pars plana vitrectomy for endogenous endophthalmitis. Retina 2005,25(6):746–750. 10.1097/00006982-200509000-00010PubMedCrossRef Zhang YQ, Wang WJ: Treatment outcomes after pars plana vitrectomy for endogenous endophthalmitis. Retina 2005,25(6):746–750. 10.1097/00006982-200509000-00010PubMedCrossRef
25.
go back to reference Lamaris GA, Esmaeli B, Chamilos G, et al.: Fungal endophthalmitis in a tertiary care cancer center: a review of 23 cases. Eur J Clin Microbiol Infect Dis 2008,27(5):343–347. 10.1007/s10096-007-0443-9PubMedCrossRef Lamaris GA, Esmaeli B, Chamilos G, et al.: Fungal endophthalmitis in a tertiary care cancer center: a review of 23 cases. Eur J Clin Microbiol Infect Dis 2008,27(5):343–347. 10.1007/s10096-007-0443-9PubMedCrossRef
26.
go back to reference Anand A, Madhavan H, Neelam V, Lily T: Use of polymerase chain reaction in the diagnosis of fungal endophthalmitis. Ophthalmology 2001,108(2):326–330. 10.1016/S0161-6420(00)00517-0PubMedCrossRef Anand A, Madhavan H, Neelam V, Lily T: Use of polymerase chain reaction in the diagnosis of fungal endophthalmitis. Ophthalmology 2001,108(2):326–330. 10.1016/S0161-6420(00)00517-0PubMedCrossRef
27.
go back to reference Coats ML, Peyman GA: Intravitreal corticosteroids in the treatment of exogenous fungal endophthalmitis. Retina 1992,12(1):46–51. 10.1097/00006982-199212010-00010PubMedCrossRef Coats ML, Peyman GA: Intravitreal corticosteroids in the treatment of exogenous fungal endophthalmitis. Retina 1992,12(1):46–51. 10.1097/00006982-199212010-00010PubMedCrossRef
28.
go back to reference Majji AB, Jalali S, Das T, Gopinathan U: Role of intravitreal dexamethasone in exogenous fungal endophthalmitis. Eye (Lond) 1999,13(Pt 5):660–665.CrossRef Majji AB, Jalali S, Das T, Gopinathan U: Role of intravitreal dexamethasone in exogenous fungal endophthalmitis. Eye (Lond) 1999,13(Pt 5):660–665.CrossRef
Metadata
Title
Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections
Authors
Jayanth Sridhar
Harry W Flynn Jr
Ajay E Kuriyan
Darlene Miller
Thomas Albini
Publication date
01-12-2013
Publisher
Springer Berlin Heidelberg
Published in
Journal of Ophthalmic Inflammation and Infection / Issue 1/2013
Electronic ISSN: 1869-5760
DOI
https://doi.org/10.1186/1869-5760-3-60

Other articles of this Issue 1/2013

Journal of Ophthalmic Inflammation and Infection 1/2013 Go to the issue